News EPFL

Jacques Fellay presented with the 2012 National Latsis Prize

Published:09.01.13 — Member of the Global Health Institute at EPFL, Jacques Fellay will be presented with the 2012 National Latsis Prize this week for his research on genetic variations in the human genome and their effects on the treatment and reaction to viruses.

A protein's life – up close and personal

Published:07.01.13 — An EPFL team has developed a technique for spying on the inner lives of cells. For the first time, scientists have used a near-infrared, light-sensitive biocompatible molecule to mark and observe the activity of proteins inside living cells.

Rethinking bacterial persistance

Published:04.01.13 — EPFL scientists used microfluidics to observe the behavior of individual tuberculosis-like bacteria in the presence of antibiotics. Their observations call into question the prevailing theory of bacterial resistance, and they have proposed a new explanation for why some bacteria become resistant. The research is published January 4, 2013 in the journal Science.

EPFL survived the end of the world, vintage 2012

Published:22.12.12 — If you are reading this sentence, it’s because December 21, 2012, was a Winter solstice like any other. We can therefore stay calm… until the announcement of the next apocalypse!

42 Million More Francs for Biocartis

Published:21.12.12 — Active in the development of a diagnostic platform, the company’s Innovation Square has just completed its fourth round of fundraising.

Valais, a “Health Valley” and the Driving Force of Tomorrow's Power

Published:19.12.12 — This morning, the Council of State of the canton of Valais in corpore and EPFL signed an agreement for the creation of the EPFL Valais Wallis academic cluster. The signing took place after a year of setting up the project announced on 10 January 2012. The Council of State, the City of Sion, EPFL and the University of Applied Sciences of Western Switzerland (HES-SO) Valais Wallis will shortly launch an architectural design competition for the future University campus that will house the first EPFL’s research chairs in 2014 and the first HES transfers in 2015.

Autoimmune disease – retraining white blood cells

Published:18.12.12 — Symptoms of an autoimmune disease disappeared after a team of scientists retrained white blood cells using a specially engineered protein. This method is extremely promising for treating diseases such as type I diabetes and multiple sclerosis.